BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14641107)

  • 1. A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95.
    Arsenijevic T; Degraef C; Dumont JE; Roger PP; Pirson I
    Biochem J; 2004 Mar; 378(Pt 2):673-9. PubMed ID: 14641107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G1/S Cyclins interact with regulatory subunit of PKA via A-kinase anchoring protein, AKAP95.
    Arsenijevic T; Degraef C; Dumont JE; Roger PP; Pirson I
    Cell Cycle; 2006 Jun; 5(11):1217-22. PubMed ID: 16721056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning, chromosomal localization, and cell cycle-dependent subcellular distribution of the A-kinase anchoring protein, AKAP95.
    Eide T; Coghlan V; Orstavik S; Holsve C; Solberg R; Skâlhegg BS; Lamb NJ; Langeberg L; Fernandez A; Scott JD; Jahnsen T; Taskén K
    Exp Cell Res; 1998 Feb; 238(2):305-16. PubMed ID: 9473338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
    Serrano M; Hannon GJ; Beach D
    Nature; 1993 Dec; 366(6456):704-7. PubMed ID: 8259215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D3 interacts with human activating transcription factor 5 and potentiates its transcription activity.
    Liu W; Sun M; Jiang J; Shen X; Sun Q; Liu W; Shen H; Gu J
    Biochem Biophys Res Commun; 2004 Sep; 321(4):954-60. PubMed ID: 15358120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ; Higgins T; Jones NC; Rozengurt E
    Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
    Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
    Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFbeta, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis.
    Coulonval K; Bockstaele L; Paternot S; Dumont JE; Roger PP
    Exp Cell Res; 2003 Nov; 291(1):135-49. PubMed ID: 14597415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between Cdc37 and Cdk4 in human cells.
    Lamphere L; Fiore F; Xu X; Brizuela L; Keezer S; Sardet C; Draetta GF; Gyuris J
    Oncogene; 1997 Apr; 14(16):1999-2004. PubMed ID: 9150368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
    Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes.
    Depoortere F; Van Keymeulen A; Lukas J; Costagliola S; Bartkova J; Dumont JE; Bartek J; Roger PP; Dremier S
    J Cell Biol; 1998 Mar; 140(6):1427-39. PubMed ID: 9508775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
    Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
    Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex.
    Wang J; Walsh K
    Cell Growth Differ; 1996 Nov; 7(11):1471-8. PubMed ID: 8930396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells.
    Van Dross R; Yao S; Asad S; Westlake G; Mays DJ; Barquero L; Duell S; Pietenpol JA; Browning PJ
    J Natl Cancer Inst; 2005 May; 97(9):656-66. PubMed ID: 15870436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
    Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X
    Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
    Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
    J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.